All Type of News
Expanded inspection of imported oriental medicines by private organization eyed
The Korea Food and Drug Administration (KFDA) has announced the revised Management Regulation of Imported Drug on March 7th, to this effect that imported oriental medicines, such as deer antler, ox bezoar and agalloch...
New price proposal of Gleevec on sharp backlash
The Joint Counter Measure Council for Gleevec Pricing and Expansion of Drug Public Benefits (hereinafter called Gleevec Pricing Council: GPC), a civic organization for fighting against Norvatis' Gleevec pricing policy...
Mounting criticism on lukewarm reactions by KPA over the reduced treatment charges
Business sources say that the Korea Pharmaceutical Association has been strongly criticized for its lukewarm countermeasures over the reduced treatment charges.
Outwardly, the KPA made a strong opposition to the re...
Trast ranks highest in brand image
Trast of SK Pharm placed in the first place having the most influential brand image among anti-arthritic drugs, according to a recent survey of Korea Management Association.
SK Pharm says that a patch type of Trast...
21% minority of pharmacies to predominate prescription filling.
The MOHW plans to take a strong preventive measure against the prescription business collusion between medical institutions and pharmacies based on the scrutinized data conducted by the HIRA (Health Insurance Reviesw ...
License procedures of oriental medicines to be further ameliorated
The Korea Food and Administration says it will establish shortly a working committee to formulate the specific license regulations and criteria for screening the safety and efficacy of oriental medicines so as to faci...
Drug industry strongly to resist against 5% drug price slash.
To save about 200 billion won of the NHI budget the MOHW is attempting to slash overall drug prices by 5% on average, which provokes rage to the drug industry.
The MOHW proposed to the drug industry for 5% price re...
Novartis proposes 24,050 won for Glivec's insurance price per tablet
Novartis Korea says that it has recently proposed to the Ministry of Health and Welfare (MOHW) the insurance price of Glivec by 24,050 won per tablet based on the local drug pricing assessment system of new drugs.
...
Zuellig's unfair contract to raise problems.
The distribution agreements made with Zuellig found unfair clauses, raising a lot of problems in the drug wholesale circles including the lawsuit against Zuellig filed by Dongwon Wholesale Co. for compensation of thei...
Stamina health foods market using silkworm and herbs getting heated
Business industry sources say that the domestic stamina health foods market, which will mark a turnover of about 10 billion won this year, has emerged as an arena of tripartite competition among the domestic firms:
...
